Literature DB >> 10754362

Frequency and clinicopathology associations of K-ras mutations in colorectal cancer in a northeast Mexican population.

S G Martinez-Garza1, A Núñez-Salazar, A L Calderon-Garcidueñas, F J Bosques-Padilla, A Niderhauser-García, H A Barrera-Saldaña.   

Abstract

Activation of the ras family gene has been implicated in colorectal tumorigenesis, K-ras being the most frequently altered gene. The frequency of K-ras codon 12, 13 and 61 point mutations in patients with colorectal neoplasias was examined. We employed a polymerase chain reaction-restriction fragment length polymorphism assay and single-strand conformational polymorphism to detect mutations. We found that point mutations at codons 12 and 13 were present in 53% and 39% of the tumors, respectively, but none at codon 61. These results agree with previous reports. Point mutations were more frequent in adenomas than in carcinomas, with villous adenomas presenting a higher incidence of mutations than other adenomas. The association between clinical and histopathological parameters was investigated. Our study is the beginning of a new research line in molecular epidemiology of colorectal cancer and is the first to be carried out in one part of the Mexican population.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10754362     DOI: 10.1159/000016940

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  9 in total

1.  Associations of Ki-ras proto-oncogene mutation and p53 gene overexpression in sporadic colorectal adenomas with demographic and clinicopathologic characteristics.

Authors:  Janine G Einspahr; Maria Elena Martinez; Ruiyun Jiang; Chiu-Hsieh Hsu; Asif Rashid; Achyut K Bhattacharrya; Dennis J Ahnen; Elizabeth T Jacobs; P Scott Houlihan; C Renee Webb; David S Alberts; Stanley R Hamilton
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-08       Impact factor: 4.254

2.  A vertically stacked, polymer, microfluidic point mutation analyzer: rapid high accuracy detection of low-abundance K-ras mutations.

Authors:  Kyudong Han; Tae Yoon Lee; Dimitris E Nikitopoulos; Steven A Soper; Michael C Murphy
Journal:  Anal Biochem       Date:  2011-06-30       Impact factor: 3.365

3.  Clinical significance of K-ras and BRAF mutations in Chinese colorectal cancer patients.

Authors:  Hong Shen; Ying Yuan; Han-Guang Hu; Xian Zhong; Xiao-Xian Ye; Mo-Dan Li; Wei-Jia Fang; Shu Zheng
Journal:  World J Gastroenterol       Date:  2011-02-14       Impact factor: 5.742

4.  Mutations in APC, CTNNB1 and K-ras genes and expression of hMLH1 in sporadic colorectal carcinomas from the Netherlands Cohort Study.

Authors:  Margreet Lüchtenborg; Matty P Weijenberg; Petra A Wark; A Merdan Saritas; Guido M J M Roemen; Goos N P van Muijen; Adriaan P de Bruïne; Piet A van den Brandt; Anton F P M de Goeij
Journal:  BMC Cancer       Date:  2005-12-15       Impact factor: 4.430

5.  Meat consumption and K-ras mutations in sporadic colon and rectal cancer in The Netherlands Cohort Study.

Authors:  M Brink; M P Weijenberg; A F P M de Goeij; G M J M Roemen; M H F M Lentjes; A P de Bruïne; R A Goldbohm; P A van den Brandt
Journal:  Br J Cancer       Date:  2005-04-11       Impact factor: 7.640

6.  Novel KRAS gene mutations in sporadic colorectal cancer.

Authors:  Walid M Naser; Mohamed A Shawarby; Dalal M Al-Tamimi; Arun Seth; Abdulaziz Al-Quorain; Areej M Al Nemer; Omar M E Albagha
Journal:  PLoS One       Date:  2014-11-20       Impact factor: 3.240

7.  KRAS, NRAS, and BRAF mutation prevalence, clinicopathological association, and their application in a predictive model in Mexican patients with metastatic colorectal cancer: A retrospective cohort study.

Authors:  Hector Eduardo Sanchez-Ibarra; Xianli Jiang; Elena Yareli Gallegos-Gonzalez; Adriana Carolina Cavazos-González; Yenho Chen; Faruck Morcos; Hugo Alberto Barrera-Saldaña
Journal:  PLoS One       Date:  2020-07-06       Impact factor: 3.240

8.  Experiences from treatment-predictive KRAS testing; high mutation frequency in rectal cancers from females and concurrent mutations in the same tumor.

Authors:  Mats Jönsson; Anna Ekstrand; Thomas Edekling; Jakob Eberhard; Dorthe Grabau; David Borg; Mef Nilbert
Journal:  BMC Clin Pathol       Date:  2009-10-15

9.  KRAS and TP53 mutations in colorectal carcinoma.

Authors:  Khawla S Al-Kuraya
Journal:  Saudi J Gastroenterol       Date:  2009 Oct-Dec       Impact factor: 2.485

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.